Summary
Updated Aug 30, 2026
Matthew Bowen is Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE). 1 SEC Form 4 filing on record, dated 7 April 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Matthew Bowen has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Matthew Bowen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Filip Janku - $1.38M of GLUE open-market activity in the last 12 months
- Markus Warmuth - $951K of GLUE open-market activity in the last 12 months
- Edmund Dunn - $483K of GLUE open-market activity in the last 12 months
- Sharon Townson - $424K of GLUE open-market activity in the last 12 months
- Anthony M. Manning - $411K of GLUE open-market activity in the last 12 months
- Jennifer Champoux - $311K of GLUE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Matthew Bowen?
Matthew Bowen is a corporate insider, tracked as Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Matthew Bowen last file a Form 4?
The only primary Form 4 on record is dated 7 April 2026.
Where can I see all of Matthew Bowen's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Matthew Bowen and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
